Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Share News (HVO)

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.30    0.00 (0.00%)
Bid:
8.10
Ask:
8.50
Spread: 0.40 (4.938%)
Market Cap: £57.14m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

hVIVO News

Hvivo signs £2m contract with new biopharma client
17 Feb 2025

Hvivo signs £2m contract with new biopharma client

(Sharecast News) - Contract research organisation Hvivo said on Monday that it has signed a £2.0m contract with a new biopharmaceutical client to...

hVIVO reports positive results from Shionogi RSV trial
5 Feb 2025

hVIVO reports positive results from Shionogi RSV trial

(Sharecast News) - hVIVO reported positive results from a phase 2a respiratory syncytial virus (RSV) human challenge trial conducted on behalf of Shio...

hVIVO wins contract for RSV drug human trial for Inhalon Biopharma
3 Feb 2025

hVIVO wins contract for RSV drug human trial for Inhalon Biopharma

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory sy...

hVIVO signs human challenge trial contract with Inhalon Biopharma
3 Feb 2025

hVIVO signs human challenge trial contract with Inhalon Biopharma

(Sharecast News) - hVIVO announced on Monday that it has signed a contract with Inhalon Biopharma to conduct a human challenge trial assessing the eff...

hVIVO eyes double-digit revenue rise, announces new acquisition
29 Jan 2025

hVIVO eyes double-digit revenue rise, announces new acquisition

(Alliance News) - hVIVO PLC on Wednesday released an optimistic pre-annual results trading update, and said it expects "further strong growth" next ye...

Hvivo acquires two clinical research units, FY revenues up 11.9pc
29 Jan 2025

Hvivo acquires two clinical research units, FY revenues up 11.9pc

(Sharecast News) - Contract research organisation Hvivo said on Wednesday that it has acquired two clinical research units from German outfit CRS Clin...

hVIVO signs LOI to conduct pivotal whooping cough study
27 Jan 2025

hVIVO signs LOI to conduct pivotal whooping cough study

(Sharecast News) - hVIVO announced on Monday that it has signed a letter of intent with ILiAD Biotechnologies to conduct a pivotal phase three human c...

hVIVO stock rises in response to vaccine testing contract
27 Jan 2025

hVIVO stock rises in response to vaccine testing contract

(Alliance News) - hVIVO PLC on Monday said it had signed a letter of intent to run phase 3 trials on ILiAD Biotechnologies LLC's whooping cough vaccin...